2018
DOI: 10.1016/j.jpeds.2017.12.058
|View full text |Cite
|
Sign up to set email alerts
|

Clinical, Pathologic, and Genetic Features of Neonatal Dubin-Johnson Syndrome: A Multicenter Study in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

5
49
6

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
3
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(60 citation statements)
references
References 26 publications
5
49
6
Order By: Relevance
“…A total of 135 patients were enrolled, 6 of whom were diagnosed with neonatal DJS. We defined neonatal cholestasis as serum direct bilirubin level (DB) greater than 1.0 mg/dL when serum total bilirubin (TB) was ≤ 5.0 mg/dL or a serum DB level greater than 20% of serum TB when serum TB was > 5.0 mg/dL [5,6]. Initial clinical symptoms, laboratory results, liver biopsy findings, and ABCC2 genetic mutations were reviewed.…”
Section: Comparison Of Subjects With Other Infants With Neonatal Cholmentioning
confidence: 99%
“…A total of 135 patients were enrolled, 6 of whom were diagnosed with neonatal DJS. We defined neonatal cholestasis as serum direct bilirubin level (DB) greater than 1.0 mg/dL when serum total bilirubin (TB) was ≤ 5.0 mg/dL or a serum DB level greater than 20% of serum TB when serum TB was > 5.0 mg/dL [5,6]. Initial clinical symptoms, laboratory results, liver biopsy findings, and ABCC2 genetic mutations were reviewed.…”
Section: Comparison Of Subjects With Other Infants With Neonatal Cholmentioning
confidence: 99%
“…A total of 135 patients were enrolled, 6 of whom were diagnosed with neonatal DJS. We de ned neonatal cholestasis as serum direct bilirubin level (DB) greater than 1.0 mg/dL when serum total bilirubin (TB) was ≤ 5.0 mg/dL or a serum DB level greater than 20% of serum TB when serum TB was > 5.0 mg/dL [5,6]. Initial clinical symptoms, laboratory results, liver biopsy ndings, and ABCC2 genetic mutations were reviewed.…”
Section: Comparison Of Subjects With Other Infants With Neonatal Cholmentioning
confidence: 99%
“…There is also increased urinary excretion of coproporphyrin I and macroscopic hepatic lysosomal black pigment accumulation. 1 Genetic testing in our patient, with parallel panel sequencing for genetic forms of cholestasis, demonstrated 2 novel heterozygous pathogenic mutations of ABCC2 associated with loss of function. The first mutation was a nonsense (c.1627C>T) variant, which introduced a premature stop codon at codon 543 [p.(Gln543*)] in exon 12, resulting in either production of a truncated protein (shortened by 1002 amino acid residues) or nonsense-mediated messenger RNA decay.…”
mentioning
confidence: 77%